InvestorsHub Logo

frrol

10/16/20 7:56 PM

#276628 RE: imho #276617

It's not a catalyst; the drug is safe and we want to do a phase 3. The FDA guidance will be on how big a trial, qualification criteria, endpoints, etc. They will be sensible.

It will be interesting to see if we actually do it in PDD and/or PD. I would imagine endpoints for both.

attilathehunt

10/17/20 12:42 AM

#276651 RE: imho #276617

"after submitting the results of the study to the FDA to obtain regulatory guidance."


That is the unknown....How long before the results of the study are available? TGD likes to beat this horse to death. Hope it isn't like the first Alzheimer's trial